GGrantIndex
← Leaderboards

Chandler Walker

Rlr Va Medical Center

$77,227
Attributed
$77,227
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $31.3K · FY201125
$50K$37.5K$25K$12.5K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$77,227 · 1
VA$0 · 3

By mechanism

F31$77,227 · 1
I01$0 · 2
IK2$0 · 1

Top collaborators

Most similar at Rlr Va Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Affect

Research focus

AffectVeteransMotor NeuronsExperimental StudyMuscleDesignEffective TherapyChronicTissuesParalysedSiteQuality Of LifeGrowthNeuromuscularNatural RegenerationNovel TherapeuticsMotorKineticsResponseInjuryAxonPreservationDoseMouse Model

Grant awards (15)

Neurogenic bone loss after SCI: skeletal rehabilitation via Wnt and exercise interactions$0
I01 · FY2025 · VA
Neurogenic bone loss after SCI: skeletal rehabilitation via Wnt and exercise interactions$0
I01 · FY2025 · VA
Exercise and NT-3-mediated lumbar motoneuron plasticity and recovery after SCI$0
I01 · FY2024 · VA · contact PI
Exercise and NT-3-mediated lumbar motoneuron plasticity and recovery after SCI$0
I01 · FY2023 · VA · contact PI
Neurogenic bone loss after SCI: skeletal rehabilitation via Wnt and exercise interactions$0
I01 · FY2023 · VA
Adipose-derived stem cell-conditioned medium therapy in a mouse model of ALS$0
IK2 · FY2023 · VA · contact PI
Neurogenic bone loss after SCI: skeletal rehabilitation via Wnt and exercise interactions$0
I01 · FY2023 · VA
Adipose-derived stem cell-conditioned medium therapy in a mouse model of ALS$0
IK2 · FY2022 · VA · contact PI
Exercise and NT-3-mediated lumbar motoneuron plasticity and recovery after SCI$0
I01 · FY2022 · VA · contact PI
Adipose-derived stem cell-conditioned medium therapy in a mouse model of ALS$0
IK2 · FY2021 · VA · contact PI
Adipose-derived stem cell-conditioned medium therapy in a mouse model of ALS$0
IK2 · FY2020 · VA · contact PI
Adipose-derived stem cell-conditioned medium therapy in a mouse model of ALS$0
IK2 · FY2019 · VA · contact PI
Grafting genetically-modified Schwann cells into a clinically-relevant SCI model$15,016
F31 · FY2013 · NS · contact PI
Grafting genetically-modified Schwann cells into a clinically-relevant SCI model$30,877
F31 · FY2012 · NS · contact PI
Grafting genetically-modified Schwann cells into a clinically-relevant SCI model$31,334
F31 · FY2011 · NS · contact PI